4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001209191-14-032368
President and CEO bought 12,500 shares at $8.00 ($100,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2014-05-07 | Purchase | +12,500 | $8.00 | $100,000 | 15,089 | D |
| Derivatives | |||||||
| Brady Todd C President and CEO | 2014-05-07 | Grant or award · Employee Stock Option (Right to Buy) | +76,068 | 76,068 | D | ||
| Open-market purchases · 12,500 sh · avg $8.00 · $100,000 | |||||||
Loading xslF345X03/doc4.xml…